SI9300595B - Peptidi z organo-protektivno aktivnostjo, postopki za njihovo pripravo in njihova uporaba v terapiji - Google Patents

Peptidi z organo-protektivno aktivnostjo, postopki za njihovo pripravo in njihova uporaba v terapiji Download PDF

Info

Publication number
SI9300595B
SI9300595B SI9300595A SI9300595A SI9300595B SI 9300595 B SI9300595 B SI 9300595B SI 9300595 A SI9300595 A SI 9300595A SI 9300595 A SI9300595 A SI 9300595A SI 9300595 B SI9300595 B SI 9300595B
Authority
SI
Slovenia
Prior art keywords
xaa
disorders
amino acid
peptides
zaa
Prior art date
Application number
SI9300595A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9300595A (en
Inventor
Predrag Sikiri
Marijan Petek
Sven Seiwerth
�eljko Grabarevi�
Ivo Rotkovi�
Marko Duvnjak
Branko Turkovi
Stjepan Mi�e
Ernest Sushanek
Boris Mildner
Ivan Udivi�i�
Original Assignee
Predrag Sikiri
Marijan Petek
Sven Seiwerth
�eljko Grabarevi�
Rotkvi Ivo
Marko Duvnjak
Branko Turkovi
Stjepan Mi�e
Suchanek Ernest
Boris Mildner
Udovi�i� Ivan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Predrag Sikiri, Marijan Petek, Sven Seiwerth, �eljko Grabarevi�, Rotkvi Ivo, Marko Duvnjak, Branko Turkovi, Stjepan Mi�e, Suchanek Ernest, Boris Mildner, Udovi�i� Ivan filed Critical Predrag Sikiri
Publication of SI9300595A publication Critical patent/SI9300595A/sl
Publication of SI9300595B publication Critical patent/SI9300595B/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI9300595A 1992-11-16 1993-11-16 Peptidi z organo-protektivno aktivnostjo, postopki za njihovo pripravo in njihova uporaba v terapiji SI9300595B (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR921283 1992-11-16

Publications (2)

Publication Number Publication Date
SI9300595A SI9300595A (en) 1994-09-30
SI9300595B true SI9300595B (sl) 2003-04-30

Family

ID=10945833

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9300595A SI9300595B (sl) 1992-11-16 1993-11-16 Peptidi z organo-protektivno aktivnostjo, postopki za njihovo pripravo in njihova uporaba v terapiji

Country Status (17)

Country Link
EP (1) EP0624164B1 (fr)
JP (1) JP2812803B2 (fr)
AT (1) ATE163131T1 (fr)
AU (1) AU5624994A (fr)
BG (1) BG61697B1 (fr)
CA (1) CA2127553C (fr)
CZ (1) CZ285155B6 (fr)
DE (1) DE69316974T2 (fr)
ES (1) ES2114170T3 (fr)
GR (1) GR3026478T3 (fr)
HU (3) HUT66303A (fr)
PL (1) PL304666A1 (fr)
RO (1) RO115733B1 (fr)
RU (1) RU2116311C1 (fr)
SI (1) SI9300595B (fr)
SK (1) SK279227B6 (fr)
WO (1) WO1994011394A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE277948T1 (de) * 1997-05-23 2004-10-15 Predrag Sikiric Bpc peptid salze mit organ-schützender aktivität, deren herstellung und therapeutische verwendung
SI24318A (sl) * 2013-03-13 2014-09-30 Diagen D.O.O. Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU176089A (sh) * 1989-09-12 1992-09-07 Sikirić, Predrag Postupak za pripremu supstancije bpc i supstancija bpc
DK0572688T3 (da) * 1992-05-30 1997-12-01 Sikiric Predrag Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi

Also Published As

Publication number Publication date
WO1994011394A3 (fr) 1994-09-15
CZ162294A3 (en) 1995-02-15
RU2116311C1 (ru) 1998-07-27
HU9303247D0 (en) 1994-03-28
CZ285155B6 (cs) 1999-05-12
EP0624164B1 (fr) 1998-02-11
BG98907A (bg) 1995-05-31
GR3026478T3 (en) 1998-06-30
DE69316974D1 (de) 1998-03-19
HUT67982A (en) 1995-05-29
BG61697B1 (bg) 1998-03-31
SI9300595A (en) 1994-09-30
HU211260A9 (en) 1995-11-28
HU9401952D0 (en) 1994-09-28
WO1994011394A2 (fr) 1994-05-26
HUT66303A (en) 1994-11-28
RO115733B1 (ro) 2000-05-30
ATE163131T1 (de) 1998-02-15
SK279227B6 (sk) 1998-08-05
EP0624164A1 (fr) 1994-11-17
RU94037232A (ru) 1996-06-20
PL304666A1 (en) 1995-01-09
JPH07507568A (ja) 1995-08-24
AU5624994A (en) 1994-06-08
CA2127553A1 (fr) 1994-05-26
DE69316974T2 (de) 1998-07-16
JP2812803B2 (ja) 1998-10-22
SK85794A3 (en) 1995-01-12
ES2114170T3 (es) 1998-05-16
CA2127553C (fr) 2003-01-28

Similar Documents

Publication Publication Date Title
JPH0532696A (ja) 副甲状腺ホルモン誘導体
ES2001274A6 (es) Un metodo para preparar peptidos que tienen influencia sobre la funcion de la glandula pituitaria en seres humanos y otros animales
IL69897A (en) Human pancreatic grf analogs,compositions comprising them and use thereof
CA2027936A1 (fr) Peptides cycliques anti-agregants
ES2055792T3 (es) Compuestos analogos ciclicos a grf.
CA2453112A1 (fr) Nouveaux peptides cationiques appartenant a la famille des dermaseptines isoles a partir de la secretion cutanee des phyllomedusa hypochondrialis
AU641215B2 (en) Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
US6743895B1 (en) Bone stimulating factor
KR0162893B1 (ko) 항응고성 펩타이드 및 이를 함유하는 조성물
JPH03120297A (ja) 抗凝固ペプチド
US5786335A (en) Sulfhydryl containing peptides for treating vascular disease
SI9300595B (sl) Peptidi z organo-protektivno aktivnostjo, postopki za njihovo pripravo in njihova uporaba v terapiji
Kiyama et al. Synthesis of porcine neuropeptide Y (NPY) in solution
HU211346A9 (en) Stabilized potent grf analogs
CA2063260A1 (fr) Peptides vasodilateurs et immunosuppresseurs
HU187503B (en) Process for preparing gonadoliberine derivatives containing beta-aspartyl group
JP2003501109A5 (fr)
WO2000075185A1 (fr) Facteur de stimulation des os
JPH05500962A (ja) 硫酸エステル基を有するヘキサペプチド

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20120627